Viewing Study NCT02638766


Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2025-12-27 @ 6:55 PM
Study NCT ID: NCT02638766
Status: COMPLETED
Last Update Posted: 2023-03-27
First Post: 2015-11-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
Sponsor: Grupo Espanol de Investigacion en Sarcomas
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module